Search results
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| Entry name | UniProt ID | Protein names | Protein classification | Related Diseases | Supporting publications (n) | EVMP confidence score | Download | |
|---|---|---|---|---|---|---|---|---|
| SEM4D | Q92854 | Semaphorin-4D (A8) (BB18) (GR3) (CD antigen CD100) | CD markersPlasma proteinsPredicted intracellular proteins | Choreiform disorder; Lung cancer; Metastatic lymph node neoplasm; Multiple sclerosis | 1 | 0.50 | ||
| TGFR1 | P36897 | TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (Activin A receptor type II-like protein kinase of 53kD) (Activin receptor-like kinase 5) (ALK-5) (ALK5) (Serine/threonine-protein kinase receptor R4) (SKR4) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) | Disease related genesEnzymesHuman disease related genes | Arterial occlusive disease; Brain cancer; Cachexia; Fibrosis; Idiopathic interstitial pneumonitis; Liver cancer; Lung cancer; Myelodysplastic syndrome; Myeloproliferative neoplasm; Pancreatic cancer; Pulmonary disease; Solid tumour/cancer; Systemic sclerosis; Ureteral cancer | 1 | 0.50 | ||
| MSLN | Q13421 | Mesothelin (CAK1 antigen) (Pre-pro-megakaryocyte-potentiating factor) [Cleaved into: Megakaryocyte-potentiating factor (MPF); Mesothelin, cleaved form] | Cancer-related genesDisease related genesPlasma proteins | Breast cancer; Cervical cancer; Endometrial cancer; Fallopian tube cancer; Liver cancer; Lung cancer; Lymphatic vessel/lymph nodes disorder; Mesothelial tumour; Mesothelin positive tumour; Metastatic malignant neoplasm; Metastatic pleura neoplasm; Non-small-cell lung cancer; Ovarian cancer; Pancreatic cancer; Peritoneal cancer; Pleural mesothelioma; Solid tumour/cancer; Stomach cancer | 5 | 0.38 | ||
| MET | P08581 | Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met) | Cancer-related genesDisease related genesEnzymes | Alzheimer disease; Biliary tract cancer; Brain cancer; Breast cancer; Cardiovascular disease; Chronic arterial occlusive disease; Colorectal cancer; Fibrosis; Glaucoma; Head and neck cancer; Heart disease; Injury; Liver cancer; Liver disease; Lung cancer; Melanoma; Metastatic lymph node neoplasm; Nasopharyngitis; Non-small-cell lung cancer; Ovarian cancer; Renal cell carcinoma; Sarcoma; Solid tumour/cancer; Stomach cancer; Thyroid cancer | 3 | 0.38 | ||
| NOTC3 | Q9UM47 | Neurogenic locus notch homolog protein 3 (Notch 3) [Cleaved into: Notch 3 extracellular truncation; Notch 3 intracellular domain] | Cancer-related genesDisease related genesHuman disease related genes | Lung cancer; Pancreatic cancer | 1 | 0.38 | ||
| RET | P07949 | Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment] | Cancer-related genesDisease related genesEnzymes | Breast cancer; Colon cancer; Colorectal cancer; Indeterminate colitis; Lung cancer; Mature B-cell lymphoma; Multiple myeloma; Myelodysplastic syndrome; Neurodegenerative disorder; Solid tumour/cancer; Thrombocytopenia; Thyroid cancer | 1 | 0.38 | ||
| S39A6 | Q13433 | Zinc transporter ZIP6 (Estrogen-regulated protein LIV-1) (Solute carrier family 39 member 6) (Zrt- and Irt-like protein 6) (ZIP-6) | Metabolic proteinsPredicted membrane proteinsTransporters | Breast cancer; Lung cancer; Non-small-cell lung cancer | 1 | 0.38 | ||
| EPHB4 | P54760 | Ephrin type-B receptor 4 (EC 2.7.10.1) (Hepatoma transmembrane kinase) (Tyrosine-protein kinase TYRO11) | Cancer-related genesDisease related genesEnzymes | Brain cancer; Cystic/dysplastic kidney disease; Lung cancer; Metastatic meninges neoplasm; Metastatic tumour; Solid tumour/cancer | 2 | 0.25 | ||
| FOLR1 | P15328 | Folate receptor alpha (FR-alpha) (Adult folate-binding protein) (FBP) (Folate receptor 1) (Folate receptor, adult) (KB cells FBP) (Ovarian tumor-associated antigen MOv18) | Endometrial cancer; Lung cancer; Malaria; Ovarian cancer; Renal cell carcinoma; Solid tumour/cancer | 2 | 0.25 | |||
| CD80 | P33681 | T-lymphocyte activation antigen CD80 (Activation B7-1 antigen) (BB1) (CTLA-4 counter-receptor B7.1) (B7) (CD antigen CD80) | CD markersFDA approved drug targetsPredicted intracellular proteins | Diabetes mellitus; Lung cancer; Lymphoma; Rheumatoid arthritis; Solid tumour/cancer; Transplant rejection | 1 | 0.25 | ||
| FGFR1 | P11362 | Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD antigen CD331) | Cancer-related genesCD markersDisease related genes | Acute diabete complication; Acute myeloid leukaemia; Alzheimer disease; Bladder cancer; Breast cancer; Chronic arterial occlusive disease; Colorectal cancer; Coronary atherosclerosis; Endometrial cancer; Epidermal dysplasias; Gram-positive bacterial infection; Idiopathic interstitial pneumonitis; Liver cancer; Lung cancer; Multiple myeloma; Myelodysplastic syndrome; Myeloproliferative neoplasm; Non-alcoholic fatty liver disease; Oesophagitis; Ovarian cancer; Peritoneal cancer; Retina cancer; Solid tumour/cancer; Stomach cancer; Thrombocytopenia; Type 2 diabetes mellitus | 1 | 0.25 | ||
| PGFRB | P09619 | Platelet-derived growth factor receptor beta (PDGF-R-beta) (PDGFR-beta) (EC 2.7.10.1) (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor) (CD140 antigen-like family member B) (Platelet-derived growth factor receptor 1) (PDGFR-1) (CD antigen CD140b) | Cancer-related genesCD markersDisease related genes | Acute diabete complication; Alzheimer disease; Gram-positive bacterial infection; Intracranial injury; Liver cancer; Lung cancer; Multiple myeloma; Myelodysplastic syndrome; Renal cell carcinoma; Solid tumour/cancer; Thrombocytopenia | 1 | 0.25 | ||
| S1PR1 | P21453 | Sphingosine 1-phosphate receptor 1 (S1P receptor 1) (S1P1) (Endothelial differentiation G-protein coupled receptor 1) (Sphingosine 1-phosphate receptor Edg-1) (S1P receptor Edg-1) (CD antigen CD363) | Cancer-related genesCD markersFDA approved drug targets | Acne vulgaris; Cardiovascular disease; Crohn disease; Cutaneous lupus erythematosus; Diabetes mellitus; Immune system disease; Liver cancer; Lung cancer; Multiple sclerosis; Postoperative inflammation; Psoriasis; Pyoderma gangrenosum; Retinopathy; Rheumatoid arthritis; Solid tumour/cancer; Ulcerative colitis | 1 | 0.25 | ||
| TIGIT | Q495A1 | T-cell immunoreceptor with Ig and ITIM domains (V-set and immunoglobulin domain-containing protein 9) (V-set and transmembrane domain-containing protein 3) | Cervical cancer; Lung cancer; Non-small-cell lung cancer; Solid tumour/cancer | 1 | 0.25 | |||
| TPBG | Q13641 | Trophoblast glycoprotein (5T4 oncofetal antigen) (5T4 oncofetal trophoblast glycoprotein) (5T4 oncotrophoblast glycoprotein) (M6P1) (Wnt-activated inhibitory factor 1) (WAIF1) | Predicted membrane proteins | Breast cancer; Lung cancer; Prostate cancer; Solid tumour/cancer | 1 | 0.25 |